Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-12 Option Award | 2024-07-15 4:39 pm | N/A 2034-07-12 | FEMASYS INC | FEMY | Silverman Joshua Director | 17,600 | $0 | 17,600 (Direct) | View |
| 2024-07-12 Option Award | 2024-07-15 4:37 pm | N/A 2034-07-12 | FEMASYS INC | FEMY | Larsen Charles Director | 17,600 | $0 | 17,600 (Direct) | View |
| 2024-07-12 Option Award | 2024-07-15 4:34 pm | N/A 2034-07-12 | FEMASYS INC | FEMY | Milnes Alistair Director | 17,600 | $0 | 17,600 (Direct) | View |
| 2024-07-12 Option Award | 2024-07-15 4:33 pm | N/A 2034-07-12 | FEMASYS INC | FEMY | Uzialko Edward R Director | 17,600 | $0 | 17,600 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-13 9:47 pm | N/A 2034-02-12 | FEMASYS INC | FEMY | Spector Richard D. Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:43 pm | N/A 2034-02-01 | FEMASYS INC | FEMY | Currie Daniel Scott Chief Operating Officer | 61,900 | $0 | 61,900 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:43 pm | N/A 2034-02-01 | FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer | 84,000 | $0 | 84,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:42 pm | N/A 2034-02-01 | FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical | 32,600 | $0 | 32,600 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:42 pm | N/A 2034-02-01 | FEMASYS INC | FEMY | Lee-Sepsick Kathy Chief Executive Officer | 204,900 | $0 | 204,900 (Direct) | View |
Ownership | 2023-11-28 5:06 pm | 2023-11-21 2025-11-21 | FEMASYS INC | FEMY | PharmaCyte Biotech Inc. 10% Owner | 0 | $0 | 12,711,864 (Direct) | View |
| 2023-11-21 Option Award | 2023-11-22 4:39 pm | N/A 2033-11-21 | FEMASYS INC | FEMY | Silverman Joshua Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-11-01 9:40 pm | N/A 2033-10-10 | FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 6:00 pm | N/A 2033-07-03 | FEMASYS INC | FEMY | Lee-Sepsick Kathy Chief Executive Officer | 542,300 | $0 | 542,300 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 6:00 pm | N/A 2033-07-03 | FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer | 309,900 | $0 | 309,900 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 6:00 pm | N/A 2033-07-03 | FEMASYS INC | FEMY | Currie Daniel Scott Senior VP, Operations | 209,400 | $0 | 209,400 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:15 pm | N/A 2033-06-21 | FEMASYS INC | FEMY | Morrissey Anne Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:15 pm | N/A 2033-06-21 | FEMASYS INC | FEMY | Perrow Wendy Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:15 pm | N/A 2033-06-21 | FEMASYS INC | FEMY | Larsen Charles Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:15 pm | N/A 2033-06-21 | FEMASYS INC | FEMY | Uzialko Edward R Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:42 pm | N/A 2033-06-14 | FEMASYS INC | FEMY | Milnes Alistair Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:41 pm | N/A 2033-06-14 | FEMASYS INC | FEMY | Kendall Keith J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2022-10-10 Option Award | 2022-10-17 4:48 pm | N/A 2032-10-10 | FEMASYS INC | FEMY | Thomas Christine E SVP, Regulatory & Clinical | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Dyett John Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Perrow Wendy Director | 8,500 | $0 | 25,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Morrissey Anne Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Larsen Charles Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Adams John Q JR Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:19 pm | N/A 2032-06-08 | FEMASYS INC | FEMY | Uzialko Edward R Director 10% Owner | 8,500 | $0 | 8,500 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-01 4:38 pm | N/A 2032-02-28 | FEMASYS INC | FEMY | Elefant Dov Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership(A) | 2022-02-24 4:22 pm | N/A N/A | FEMASYS INC | FEMY | Larsen Charles Director | 0 | $0 | 13,889 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 9:12 pm | N/A 2032-01-25 | FEMASYS INC | FEMY | Currie Daniel Scott Senior VP, Operations | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 9:10 pm | N/A 2032-01-25 | FEMASYS INC | FEMY | Perrow Wendy Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-12-15 Other | 2021-12-17 5:12 pm | N/A N/A | FEMASYS INC | FEMY | Dyett John Director | 3,395,430 | $0 | 3,685,774 (Indirect) | View |